SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-233712
Filing Date
2007-11-02
Accepted
2007-11-02 15:10:46
Documents
5
Period of Report
2007-11-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 15989
2 PLACEMENT AGENCY AGREEMENT dex11.htm EX-1.1 110336
3 OPINION OF WYRICK ROBBINS YATES & PONTON LLP dex51.htm EX-5.1 6620
4 FORM OF SUBSCRIPTION AGREEMENT dex1012.htm EX-10.12 50061
5 PRESS RELEASE dex991.htm EX-99.1 6135
  Complete submission text file 0001193125-07-233712.txt   190779
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 071210254
SIC: 2836 Biological Products, (No Diagnostic Substances)